Primary focus: immune engineering for vaccines and cancer immunotherapy. Quantum sensing relevance: co-authored 2025 fluorescent-protein spin qubit paper (Physics World Top-10) with Maurer and Awschalom, contributing protein engineering expertise to develop biological alternatives to NV centers. Collaborates on quantum biosensors for real-time monitoring of immune cell activity (Chan Zuckerberg Biohub). Primarily a collaboration gateway for NV biosensing rather than standalone quantum sensing PI.

Garrido is a computational cognitive neuroscientist — predictive coding, Bayesian brain models, neuroimaging biomarkers for mental health — who was appointed a chief investigator of the ARC Centre of Excellence in Quantum Biotechnology specifically to work with the Melbourne and UQ physics groups on non-invasive quantum-sensor recording of human brain magnetic fields. She is the human-subject and source-reconstruction end of the QUBIC portable-brain-imager programme: her lab supplies the paradigms, the clinical cohorts and the inverse-problem modelling that a diamond- or OPM-based MEG system has to serve. Positioned against the established body of NV-ensemble quantum sensing work — DEER, nanoscale NMR and T1 relaxometry protocols operating at pT/sqrt(Hz) field sensitivity — she is not a sensor developer, but she is the reason the pT/sqrt(Hz)-class magnetometers being built at Melbourne have a human-trials pathway at all. Preferred attributes present in strength: bioelectromagnetism and human trials with novel quantum technologies. Included as a deliberate borderline case — a sensing postdoc would be the physics half of a collaboration with this lab, not a member of it.

Goldys was Deputy Director of the ARC Centre of Excellence for Nanoscale BioPhotonics and now leads a nanoscale biophotonics group in Biomedical Engineering. The programme is about extracting diagnostic information from very weak optical signals inside cells and tissue: luminescent and upconverting nanoparticle probes with long lifetimes that allow time-gated, background-free detection; hyperspectral unmixing of native cellular autofluorescence (NADH, FAD, porphyrins) as a completely label-free readout of cell state, which she has pushed toward clinical use in reproductive medicine and cancer; and nanoparticle-mediated therapy. Positioned against the established body of NV-ensemble quantum sensing work — DEER, nanoscale NMR and T1 relaxometry protocols operating at pT/sqrt(Hz) field sensitivity — time-gated luminescence and NV relaxometry are two solutions to the same problem — how to read a faint, specific signal out of an autofluorescent, optically hostile biological background — and her clinical translation experience is exactly the missing capability in most quantum-biosensing groups. Preferred attribute present: advanced/label-based imaging with a genuine human-application pathway.

Hemmer pioneered NV-diamond spin sensing and super-resolution with spin defects, working on coherent control, photonic integration of NV sensors, and diamond-based magnetometry/imaging bridging physics and engineering. In the broader landscape of NV-centre ensemble quantum sensing (DEER, nano-NMR, T1 relaxometry) operating near pT/sqrt(Hz) sensitivity, this work is directly in the NV ensemble sensing lineage, emphasizing photonic integration and super-resolution readout.

Hollenberg is the intellectual centre of gravity for diamond quantum sensing in Australia: a theorist-turned-programme-leader whose group develops NV-based quantum probes for biological systems and quantum-computing architectures in silicon and diamond. Current directions include the quantum-probe hyperspectral microscope, in which NV ensembles in a bulk diamond substrate report magnetic and spin-noise contrast from cells cultured directly on the surface; nanodiamond quantum probes for intracellular relaxometry and free-radical detection; theory of decoherence-based sensing (T1 relaxometry as a chemical-specificity channel rather than a nuisance); and single-cell magnetic resonance. He co-leads the Melbourne node of the ARC Centre of Excellence in Quantum Biotechnology (QUBIC) with Simpson and Hinde, which is explicitly chartered to build quantum sensors for live biology, including portable brain imagers. Positioned against the established body of NV-ensemble quantum sensing work — DEER, nanoscale NMR and T1 relaxometry protocols operating at pT/sqrt(Hz) field sensitivity — his programme is one of the small number worldwide that has carried those ensemble protocols all the way into cell culture and tissue rather than stopping at proof-of-principle magnetometry. Preferred attribute present: the group's emphasis is on sensitivity and biological specificity rather than device fabrication, and QUBIC funding runs to 2030 with recurring postdoc recruitment.

Krueger's chemistry group develops diamond and nanodiamond surface chemistry, functionalization and bioconjugation that make NV centres viable, shallow, coherent quantum sensors for chemical and biological targets - the materials-chemistry enabler for NV ensemble sensing. She co-leads Stuttgart's quantum-technologies profile. In the broader landscape of NV-centre ensemble quantum sensing (DEER, nano-NMR, T1 relaxometry) operating near pT/sqrt(Hz) sensitivity, this work is enabled at the surface-chemistry level by this work.

Kuncic works across medical physics and nanoscale systems: nanoparticle-enhanced radiotherapy and dosimetry (where high-Z nanoparticles act as local dose amplifiers and the physics question is energy deposition at nanometre scales), nanoparticle contrast agents and theranostics, and — separately — neuromorphic nanowire networks as physical computing substrates. The medical-physics thread is the relevant one here: it is about quantifying and imaging what a nanoscale probe does inside tissue. Positioned against the established body of NV-ensemble quantum sensing work — DEER, nanoscale NMR and T1 relaxometry protocols operating at pT/sqrt(Hz) field sensitivity — the nanoparticle-in-tissue problem she works on is the same delivery-and-quantification problem that determines whether an in-cell nanodiamond sensor operating near the pT/sqrt(Hz) regime reports anything biologically meaningful. Borderline inclusion; a candidate would be bringing quantum sensing to her, not the reverse.

Develops quantum sensing platforms at the biology interface. Core NV-center work: (1) widefield NV magnetic imaging of action potentials in neurons and cardiac tissue; (2) NV-based single-molecule NMR at 14 T resolving molecular structure with single-molecule sensitivity; (3) charge-sensitive shallow NV nanoprobes monitoring real-time cellular electrophysiology; (4) biocompatible diamond surface functionalization enabling multiplexed DNA microarray biosensing; (5) fluorescent-protein spin qubits as biological alternatives to diamond NV (2025 paper, Physics World Top-10 Breakthrough). Runs full NV stack: hot implantation, widefield and confocal ODMR, T1/T2/Hahn echo/DEER/Rabi, automated fitting pipelines. 2026 Sloan Fellow. PhD Lukin/Harvard; postdoc Chu/Stanford. Argonne joint appointment.

McCamey is, for a candidate coming from NV ensemble sensing, the single most methodologically adjacent PI at UNSW. His laboratory does optically and electrically detected magnetic resonance on spins that are not defects in diamond: photogenerated spin-correlated radical pairs, triplet excitons in organic semiconductors, singlet-fission intermediates, and molecular spin systems. The instrumentation is the same toolkit — pulsed EPR, ODMR, dynamical decoupling, relaxometry — applied to systems where the spin is created by light and reports on chemistry. He directs the UNSW node of ARC Exciton Science. Positioned against the established body of NV-ensemble quantum sensing work — DEER, nanoscale NMR and T1 relaxometry protocols operating at pT/sqrt(Hz) field sensitivity — his group runs precisely those pulse sequences (Hahn echo, DEER, relaxometry) on a different spin species, and radical-pair spin chemistry is one of the few plausible mechanisms by which biology could be genuinely quantum — which makes this a strong landing spot for someone wanting to keep the NV skill set but change the physical system. Preferred attributes present: sensitivity-limited spin measurement, quantum-biology relevance.

Simpson runs the experimental quantum imaging and sensing laboratory at Melbourne and is the closest match at this institution to a bio-oriented NV sensing postdoc. Two active threads: (i) widefield NV magnetic and spin-relaxation imaging of living cells and tissue, including magnetic imaging of magnetotactic bacteria, cellular free radicals and paramagnetic ion transport, and quantum-probe imaging of neuronal activity; and (ii) engineering Australia's most sensitive diamond vector magnetometer with RMIT and Phasor Innovation, aimed at navigation, underground/undersea sensing and, explicitly, mapping magnetic signals of the human brain in unshielded environments. That second thread is a direct bid at bioelectromagnetism with a quantum sensor. Positioned against the established body of NV-ensemble quantum sensing work — DEER, nanoscale NMR and T1 relaxometry protocols operating at pT/sqrt(Hz) field sensitivity — Simpson's work is a continuation of exactly that lineage, pushing ensemble DEER/T1-relaxometry contrast mechanisms out of the physics lab and into cell biology and human-scale magnetoencephalography. Preferred attributes present: bioelectromagnetism, human-subject ambitions, sensitivity-limited (not fabrication-limited) programme. QUBIC investigator; recruits postdocs regularly.